Maven Securities’s OptiNose OPTN Stock Holding History

Maven Securities’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,000	Closed	-$566K	–	150
2018 Q3	$566K	Sell	3,000 -333	-10%	-$94.9K	0.21%	96
2018 Q2	$1.4M	Buy	3,333 +2,320	+229%	+$782K	0.78%	32
2018 Q1	$304K	Sell	1,013 -678	-40%	-$188K	0.16%	63
2017 Q4	$480K	Buy	+1,691	New	+$476K	0.24%	39

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maven Securities's OPTN Position: Q4 2018 in Review

Maven Securities sold out of OptiNose (OPTN) in Q4 2018, closing a stake of 3,000 shares — an estimated $566K sold.

Maven Securities first reported a position in OPTN in Q4 2017 and held it in 4 quarters. The position peaked at $1.4M in Q2 2018. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2018.

Maven Securities reported no remaining OptiNose position as of Q4 2018 after selling out during the quarter.
Maven Securities sold 3,000 OptiNose shares in Q4 2018, an estimated $566K.
Maven Securities first reported a position in OptiNose in Q4 2017 and held it in 4 quarters.
Maven Securities's OptiNose position peaked at $1.4M in Q2 2018.
67 funds tracked by Wall St. Rank held OptiNose as of Q4 2018.

Based on Maven Securities's 13F filing for Q4 2018, filed 14 Feb 2019.